Nordic ListingsIssuer Report
XP Chemistries AB: Quarterly Trading Report 2025 Q3
XP Chemistries AB: Quarterly Trading Report 2025 Q3https://view.news.eu.nasdaq.com/view?id=b498ea156d82f48e5c6d580c116121ba8&lang=en&src=omxlink
XP Chemistries AB: Quarterly Trading Report 2025 Q3
Earlier from XP Chemistries
- XPC: EU approval paves way for commercial launch; rights issue boosts capital for growth
- XPC: EFSA approval for capsaicin positions XP Chemistries for EU market launch in 2025
- XPC: Narrowed losses and regulatory progress position XP Chemistries for a 2025 commercial launch
- XPC: Q3 2024 saw lower sales, improved losses, and a regulatory delay for XP Chemistries
- XPC: XP Chemistries advanced EFSA approval and improved margins, preparing for a 2025 launch
Later from XP Chemistries
- XP Chemistries Q3 Operating Loss SEK 2.6 Mln
- XP Chemistries Signs LoI With European Distributor For Launch Of Capsaicin For Animal Feed
- Xp Chemistries Q4 Ooper Loss SEK 3.3 Mln
- XPC: Q1 2026 saw higher sales, deeper commercialization, and a strengthened IP position
Follow XP Chemistries into a list and get an email when it puts out news.
Follow XP Chemistries